Delivery Order SPE2DB24D2205-SPE2DB24FDWDX
Award Date
6/27/24
Potential Completion Date
6/28/24
Potential Value
$28K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml. The $30,161.60 firm fixed-price contract has a completion date of May 25, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $2,494.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a medical product used in healthcare applications. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, and has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.99, is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a prescription medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,054.69, is a Firm Fixed Price Delivery Order for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty medication. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,146.73, is a delivery order for the product "PULMOZYME 1 MG/ML AMPUL 2.5ML" with a completion date of March 6, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,207.62 Firm Fixed Price delivery order is for the supply of Pulmozyme 1 mg/ml ampuls (2.5 ml). The contract has an ultimate completion date of August 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) for the delivery of Pulmozyme 1 mg/ml ampul 2.5ml. The contract is a firm fixed-price Delivery Order with a ceiling value of $22,356.82 and a completion date of April 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a specialty medication. The $5,231 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,187.41 Firm Fixed Price Delivery Order contract is for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a specialty respiratory medication. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,988.66 firm fixed-price delivery order is for Pulmozyme 1 mg/mL ampules (2.5 mL) and has a completion date of November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a broad range of...